CRIS Current Research Information System

BRILLANTI, STEFANO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.406
EU - Europa 1.407
AS - Asia 1.238
AF - Africa 122
SA - Sud America 63
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 5.240
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.393
SG - Singapore 456
CN - Cina 406
GB - Regno Unito 391
IT - Italia 200
DE - Germania 198
SE - Svezia 186
IN - India 117
HK - Hong Kong 110
VN - Vietnam 84
RU - Federazione Russa 81
UA - Ucraina 71
FR - Francia 63
IE - Irlanda 58
NL - Olanda 48
CI - Costa d'Avorio 44
BR - Brasile 40
ZA - Sudafrica 35
EE - Estonia 32
TG - Togo 21
JP - Giappone 18
BE - Belgio 15
FI - Finlandia 14
CH - Svizzera 13
KR - Corea 13
AR - Argentina 12
BG - Bulgaria 10
CA - Canada 10
JO - Giordania 10
NG - Nigeria 10
AT - Austria 9
SC - Seychelles 9
IR - Iran 7
EC - Ecuador 6
ID - Indonesia 5
PL - Polonia 5
ES - Italia 4
GR - Grecia 4
BD - Bangladesh 3
CZ - Repubblica Ceca 2
IQ - Iraq 2
MX - Messico 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
TR - Turchia 2
AU - Australia 1
CL - Cile 1
CO - Colombia 1
EG - Egitto 1
ET - Etiopia 1
EU - Europa 1
IL - Israele 1
PE - Perù 1
PH - Filippine 1
PK - Pakistan 1
PY - Paraguay 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
SV - El Salvador 1
TW - Taiwan 1
VE - Venezuela 1
Totale 5.240
Salva come PNG Salva come JPEG
Città #
Southend 348
Singapore 316
Fairfield 274
Ashburn 260
Chandler 162
Wilmington 134
Ann Arbor 121
Woodbridge 112
Houston 111
Hong Kong 110
Santa Clara 102
Seattle 99
Boardman 82
Cambridge 78
Princeton 78
Beijing 67
Dallas 59
Dublin 57
Hefei 48
Abidjan 44
Jacksonville 42
Bologna 36
Nanjing 36
Westminster 34
New York 30
Padova 29
Los Angeles 27
Dong Ket 25
Milan 22
Saint Petersburg 22
Lomé 21
Medford 20
Buffalo 19
Tokyo 18
Dearborn 16
Shenyang 16
Bremen 15
Brussels 15
Florence 15
Hanoi 15
Ho Chi Minh City 15
San Diego 15
Berlin 14
Munich 14
Seoul 13
Falls Church 12
Monmouth Junction 12
Redondo Beach 12
Abeokuta 10
Amman 10
Frankfurt am Main 10
Guangzhou 10
Sofia 10
Tianjin 10
Jinan 9
Mülheim 9
Redmond 9
Bern 8
Changsha 8
Redwood City 8
Bari 7
Dolo 7
London 7
Norwalk 7
Phoenix 7
Turin 7
Turku 7
Hebei 6
Helsinki 6
Jiaxing 6
Nanchang 6
Wuhan 6
Yubileyny 6
Ardabil 5
Des Moines 5
Falkenstein 5
Forlì 5
Fuzhou 5
Haiphong 5
Hangzhou 5
Lake Forest 5
Shanghai 5
Siena 5
São Paulo 5
Washington 5
Alessandria 4
Bengaluru 4
Chengdu 4
Haikou 4
Kunming 4
Moscow 4
Toronto 4
Vienna 4
Xi'an 4
Amsterdam 3
Brooklyn 3
Casalecchio di Reno 3
Curitiba 3
Da Nang 3
Imola 3
Totale 3.552
Salva come PNG Salva come JPEG
Nome #
Hepatocellular carcinoma risk assessment by the measurement of liver stiffness variations in HCV cirrhotics treated with direct acting antivirals 183
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 178
Reactivation of Crohn's disease after pandemic aH1N1 and seasonal flu vaccinations. 173
Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study 171
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 163
Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice 162
Higher doses of peginterferon alpha-2b administered twice weekly improve sustained virological response in difficult-to-treat patients with chronic hepatitis C: results of a pilot randomized study 159
Ribavirin for chronic hepatitis C: And the mystery goes on. 157
Role of amantadine and other adjuvant therapies in the treatment of hepatitis C. 156
Imaging features of microvascular invasion in hepatocellular carcinoma developed after direct-acting antiviral therapy in HCV-related cirrhosis 156
The Italian compassionate use of sofosbuvir observational cohort study for the treatment of recurrent hepatitis C: clinical and virological outcomes 154
Terapia cellulare in Epatologia 149
Spleen stiffness decrease as mirror of portal hypertension changes after successful interferon-free therapy in chronic-HCV patients 144
Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C. 144
Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: Predictive role in HCC development in cirrhotic patients 143
Spleen stiffness mirrors changes in portal hypertension after successful interferon-free therapy in chronic-hepatitis C virus patients 143
Spleen stiffness measurement: A useful prognostic tool in HCV patients treated with DAAs regimens 138
THU-492 - Liver stiffness and serum fibrosis biomarker variations after DAAs treatment: predictive role in hepatocellular carcinoma development in in cirrhotic patients 136
Imaging Features of Microvascular Invasion in Hepatocellular Carcinoma Developed in HCV-Related Cirrhosis after Direct-Acting Antiviral Therapy. 127
Direct antiviral therapy for hepatitis C and hepatocellular carcinoma: facing the conundrum 127
THU-490 - Spleen stiffness measurement: a useful prognostic tool in HCV patients treated with DAAs regimens 126
Spleen Stiffness Measurements Predict the Risk of Hepatic Decompensation after Direct-Acting Antivirals in HCV Cirrhotic Patients 124
Proctosigmoidite ulcerosa refrattaria e recidivante alla terapia topica trattata con beclometasone dipropionato orale 122
Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3. 119
Indocyanine green retention test predict the risk of portal hypertension-related events after direct-acting antiviral therapy in compensated advanced chronic liver disease patients 113
Trattamento della Epatite da HCV 112
Severe acute autoimmune hepatitis after natalizumab treatment. 112
Loss and seroconversion of hepatitis B surface antigen after vaccine therapy in chronic hepatitis B patients treated with nucleoside/nucleotide analogues. 111
HEPATIC DECOMPENSATION RISK IS REDUCED, BUT NOT ELIMINATED AFTER DIRECT-ACTING ANTIVIRALS: THE ROLE OF SPLEEN STIFFNESS MEASUREMENT 108
null 107
Evaluation of Drug Interactions in Patients Treated with DAAs for Hepatitis C Therapy with Comorbidities and Cardiovascular Issues-A Delphi Consensus Project 105
Enhanced response to peginterferon-alpha-2a based triple therapy in previously non-responsive chronic hepatitis C: Final results of PRETTY study. 104
RIBAVIRIN PRIMING ENHANCES EFFICACY OF CHRONIC HEPATITIS C RE-TREATMENT IN PATIENTS WHO HAD NOT RESPONDED TO PREVIOUS COMBINATION THERAPY 104
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals 104
DEVELOPMENT OF HEPATOCELLULAR CARCINOMA IN HCV CIRRHOTIC PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 97
null 96
A multimedia multilanguage web-based platform can assess and increase the awareness on HCV infection of Pakistani people living in Italy 95
VIROLOGICAL FAILURES TO NEW DIRECT ACTING ANTIVIRALS IN A REAL LIFE SETTING MAY REQUIRE UNCONVENTIONAL REGIMENS FOR RE-TREATMENT 92
Prospective evaluation of aberrant p16 methylation in serum of patients before and after therapy for localized HCC. 88
Safety and efficacy of direct-acting antivirals for the treatment of chronic hepatitis C in a real-world population aged 65 years and older 87
La ribavirina nell'epatite cronica C: storia e segreti di un grande successo. 83
Low recurrence rate of hepatocellular carcinoma after liver transplantation: Better patient selection or lower immunosuppression? 53
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 17
Serum pepsinogen I and II concentrations and IgG antibody to Helicobacter pyloni in dyspeptic patients 16
Totale 5.358
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.341
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.341
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021270 0 0 0 0 0 18 10 28 56 47 29 82
2021/2022829 42 39 33 53 71 49 15 39 30 47 291 120
2022/2023721 74 84 40 106 59 63 16 40 122 17 59 41
2023/2024236 12 48 16 17 31 50 10 9 25 4 1 13
2024/2025899 39 149 86 57 154 42 54 28 1 66 29 194
2025/2026877 179 130 191 127 224 26 0 0 0 0 0 0
Totale 5.358